Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Canada Inspection
/
GlaxoSmithKline Biologicals

CANADA INSPECTION

•GlaxoSmithKline Biologicals•May 20, 2022

Canada Inspection 80727 - GlaxoSmithKline Biologicals - May 20, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This CANADA INSPECTION record concerns GlaxoSmithKline Biologicals, with an inspection on May 20, 2022, covering drugs.

Company: GlaxoSmithKline Biologicals
Inspection Date: May 20, 2022
Product Type: Drugs

Open in Dashboard

ID · 194d8109-abf6-45bc-85ee-a4165c4b9839

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

Canada Inspection 80727 - GlaxoSmithKline Biologicals - May 20, 2022 | Global Key Solutions